Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi-Yi Chen

Showing results (11-20 of 132) with videos related to

Pageof 14
Sort By:
BMC Infectious Diseases|April 10, 2022
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCVChih-Wei Tseng, Wen-Chun Liu, Chi-Yi Chen, et al.
Journal of Clinical Ultrasound : JCU|July 9, 2011
Role of endoscopic sonography in the diagnosis of a fish bone perforation of the gastric wall resulting in a submucosal pseudotumorChing-Hsiu Huang, Ching-Chung Chiang, Yuan-Horng Yan, et al.
The Science of the Total Environment|March 27, 2012
Increased serum level of epidermal growth factor receptor in liver cancer patients and its association with exposure to arsenicTzu-I Sung, Ying-Jan Wang, Chi-Yi Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2017
An increase in BAG-1 by PD-L1 confers resistance to tyrosine kinase inhibitor in non-small cell lung cancer via persistent activation of ERK signallingPo-Lin Lin, Tzu-Chin Wu, De-Wei Wu, et al.
American Journal of Cancer Research|May 6, 2020
Cisplatin sensitivity mediated by NKX2-1 in lung adenocarcinoma is dependent on p53 mutational status via modulating TNFSF10 expressionMing-Jenn Chen, Po-Ming Chen, Lee Wang, et al.
Oncotarget|February 14, 2018
PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expressionJai-Nien Tung, Po-Lin Lin, Yao-Chen Wang, et al.
Oncotarget|March 24, 2018
MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2Ming-Jenn Chen, De-Wei Wu, Gao-Chang Wang, et al.
Journal of Viral Hepatitis|April 4, 2020
Characteristics of regulatory T-cell function in patients with chronic hepatitis B and C coinfectionChih-Wei Tseng, Shu-Fen Wu, Chi-Yi Chen, et al.
Journal of Hepatocellular Carcinoma|October 20, 2025
Prediction Model for Risk of Hepatocellular Carcinoma After Hepatitis C Viral EradicationWei-Fan Hsu, Ching-Chu Lo, Kuo-Chih Tseng, et al.
World Journal of Clinical Oncology|April 28, 2025
Multidisciplinary tumor board is associated with improved survival in patients with hepatocellular carcinoma after liver transplantationLi Zhang, Jian Yang, Jun-Jie Li, et al.
Pageof 14

Showing results (11-20 of 132) with videos related to

Sort By:
Pageof 14
BMC Infectious Diseases|April 10, 2022
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCVChih-Wei Tseng, Wen-Chun Liu, Chi-Yi Chen, et al.
Journal of Clinical Ultrasound : JCU|July 9, 2011
Role of endoscopic sonography in the diagnosis of a fish bone perforation of the gastric wall resulting in a submucosal pseudotumorChing-Hsiu Huang, Ching-Chung Chiang, Yuan-Horng Yan, et al.
The Science of the Total Environment|March 27, 2012
Increased serum level of epidermal growth factor receptor in liver cancer patients and its association with exposure to arsenicTzu-I Sung, Ying-Jan Wang, Chi-Yi Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2017
An increase in BAG-1 by PD-L1 confers resistance to tyrosine kinase inhibitor in non-small cell lung cancer via persistent activation of ERK signallingPo-Lin Lin, Tzu-Chin Wu, De-Wei Wu, et al.
American Journal of Cancer Research|May 6, 2020
Cisplatin sensitivity mediated by NKX2-1 in lung adenocarcinoma is dependent on p53 mutational status via modulating TNFSF10 expressionMing-Jenn Chen, Po-Ming Chen, Lee Wang, et al.
Oncotarget|February 14, 2018
PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expressionJai-Nien Tung, Po-Lin Lin, Yao-Chen Wang, et al.
Oncotarget|March 24, 2018
MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2Ming-Jenn Chen, De-Wei Wu, Gao-Chang Wang, et al.
Journal of Viral Hepatitis|April 4, 2020
Characteristics of regulatory T-cell function in patients with chronic hepatitis B and C coinfectionChih-Wei Tseng, Shu-Fen Wu, Chi-Yi Chen, et al.
Journal of Hepatocellular Carcinoma|October 20, 2025
Prediction Model for Risk of Hepatocellular Carcinoma After Hepatitis C Viral EradicationWei-Fan Hsu, Ching-Chu Lo, Kuo-Chih Tseng, et al.
World Journal of Clinical Oncology|April 28, 2025
Multidisciplinary tumor board is associated with improved survival in patients with hepatocellular carcinoma after liver transplantationLi Zhang, Jian Yang, Jun-Jie Li, et al.
Pageof 14